Understanding US FDA Regulatory Responsibilities for Cell Therapy Companies - Phacilitate
Sep 9 2021
11:00 AM - 12:00 PM
Barbara Binzak Blumenfeld, shareholder and Tina Hu-Rodgers, counsel in the firm’s Life Sciences industry group, will be leading a Phacilitate Exchange webinar, “Understanding US FDA Regulatory Responsibilities for Cell Therapy Companies.” The program will cover an in-depth analysis of what cell therapy companies need to know about working with FDA during a product development program.
Professionals
Related Services & Industries
Related Offices
Related Keywords